One organization that is on a mission of providing solutions to patients who have blood cancer is Amphivena Therapeutics. The firm does this through developing immunotherapeutics that are offered to these patients with the aim of restoring the blood cell and the body’s immunity. The company’s goal is to help in saving the cancer patients lives by reestablishing cellular balance where the blood can regenerate the dead cells such as the white blood cells. The company continues to believe that if the patient’s blood can flow properly, form well, circulates as needed and function as required, then the tumor can be destroyed by the help of the immune system.
The firm was founded in 2003 and through the years, it has been able to achieve its goals and mission. It has been able to become successful through establishing healthy relationships with other pharmaceutical companies. Through developing healthy relationships, it becomes easy to get assistance when they require or updated on the changing environment and advanced technology. Knowledge can also be shared through friendships and collaboration. The firm is currently being led by JeanMarie Guenot who we can say she is perfect for the job considering her past work experience and academic credentials.
Having nearly twenty years of experience in the pharmaceutical and biotech industry has proven to be a good thing for JeanMarie as she has the knowledge, confidence, and ambition to become successful. Having a leader who has those virtues will surely take your company far, and Amphivena acts as a proof for that. She is well experienced when it comes to matters of establishing or re-establishing a firm. Jean Marie attained her MBA from the University of Pennsylvania before heading to the University of California to receive her Ph.D. While at the University of California, she was able to study various things such as how to design drugs, physical chemistry, medicinal chemistry and molecular dynamics.
JeanMarie Guenot was once an employee at Atlas Venture Capital where she acted as the investment manager. She also worked at Hoffmann as a principal scientist before she decided to found her own start-up company SKS Ocular. All these places were responsible for molding her to be a great leader and become successful. She trusts she will continue to take Amphivena to more excellent places helping it to continue achieving its goals and objectives.